Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2026-08-24

Clinical Trial Results: Improve PAD PERformance With METformin [Phase 3]

View source ↗

Summary

Phase 3 clinical trial results for metformin added to standard care in Peripheral Artery Disease.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • metformin (metformin)

Snippet

Sponsor: Northwestern University | Conditions: Peripheral Artery Disease | Phase 3 | Status: COMPLETED | Results posted: 2026-08-24